Open Field Capital LLC, founded in 2003 and based in New York, specializes in managing portfolios within the emerging technology sector. The firm's principals, who have collaborated for over 15 years, possess extensive experience in financial markets, particularly in emerging technologies. Open Field Capital is dedicated to developing investment strategies tailored to the unique characteristics of this dynamic sector. As a Registered Investment Adviser, the firm focuses on public equity and venture investments, leveraging its deep industry knowledge to navigate the complexities of emerging technologies.
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
Mojo Vision
Series C in 2023
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
Delfi Diagnostics
Series B in 2022
Delfi Diagnostics, Inc. is a biotechnology company based in Baltimore, Maryland, focused on the early detection of cancer through innovative blood tests. Founded in 2019, the company utilizes artificial intelligence and genome sequencing to identify unique patterns of DNA fragmentation in patients' blood. By employing machine learning techniques, Delfi Diagnostics develops high-precision, non-invasive tests that aim to detect cancer at a stage when it is most treatable. Their technology enables healthcare professionals to recognize previously unrecognized cancer-associated cell-free DNA fragments, facilitating timely and effective treatment options for patients.
Neo Cybernetica
Seed Round in 2022
Neo Cybernetica specializes in the development of cybernetics technology aimed at enhancing the capabilities of artificial intelligence systems. By leveraging advanced communication and automatic control systems, the company focuses on creating AI systems that can operate independently as well as collaborate effectively with humans. This innovative approach positions Neo Cybernetica to address future opportunities and challenges, ultimately contributing to the advancement of AI technologies that can benefit society in the coming decades.
Mojo Vision
Series B in 2022
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
dClimate
Seed Round in 2021
dClimate is a decentralized marketplace designed to standardize, monetize, and distribute climate data, forecasts, and models. By connecting data publishers directly with consumers, dClimate enhances the accessibility and reliability of climate information. The platform scores data for reliability when providers share their forecasts, allowing users to make informed decisions based on trustworthy information. This innovative approach creates a straightforward distribution mechanism that enables data providers to monetize their work while supporting a uniform architecture that ensures data immutability. dClimate serves a diverse range of users, including businesses, farmers, multinational corporations, and governments, facilitating timely, data-driven decision-making in the face of climate challenges.
Genesis Therapeutics
Series A in 2020
Genesis Therapeutics Inc. is a biotechnology company based in South San Francisco, California, that focuses on developing small molecule drug candidates aimed at treating patients with severe and debilitating disorders. Established in 2019, the company harnesses a proprietary artificial intelligence platform that employs advanced deep neural networks and biophysical simulation techniques to enhance drug discovery and molecular design. By combining these innovative technologies with a scalable computing infrastructure, Genesis Therapeutics aims to improve the efficiency and accuracy of molecular research. This approach not only facilitates the generation and analysis of novel drug candidates but also holds the potential to significantly advance clinical outcomes in the medical community.
Turntide
Venture Round in 2020
Turntide is a company focused on creating sustainable technologies aimed at reducing energy consumption and operational expenses in various sectors, including buildings, agriculture, and electric transportation. Founded in 2013 and headquartered in Sunnyvale, California, Turntide has developed an innovative electric motor system that utilizes advanced switched reluctance technology. This system is managed by sophisticated cloud software and incorporates IoT connectivity for precise control. By targeting the significant energy waste attributed to traditional electric motors, Turntide aims to support the shift away from fossil fuels and promote a more sustainable future. The company's efforts are geared towards eliminating the 25% of global electricity consumption that is currently wasted, thereby accelerating the transition to 100% renewable energy.
Rain AI
Seed Round in 2020
Rain AI is a semiconductor company that specializes in the development of energy-efficient hardware for artificial intelligence applications. It focuses on creating neuromorphic chips that draw inspiration from the architecture of the human brain, aiming to enhance the efficiency of AI processing. Rain AI's technology is designed to be adaptable for various applications, ranging from data centers to edge devices, thereby supporting the increasing demand for sustainable computing solutions. The company also develops learning algorithms and scaling architecture for a comprehensive neuromorphic roadmap, allowing for the creation of physical artificial neural networks. This innovation enables companies to build processors that operate with reduced costs while paving the way toward the development of advanced artificial intelligence systems.
Juvena Therapeutics
Seed Round in 2020
Juvena Therapeutics, Inc. is a biopharmaceutical company based in San Mateo, California, founded in 2017. The company specializes in developing protein-based therapeutics aimed at promoting tissue rejuvenation and addressing age-related diseases in the elderly. Its innovative platform focuses on discovering novel therapeutics that restore cellular functions, targeting conditions such as sarcopenia, wound healing, and neural regeneration. By decoding secreted proteins, Juvena Therapeutics aims to provide solutions for chronic and rare diseases, enhancing the quality of life for aging populations.
HeartVista
Series A in 2020
HeartVista is a medical technology company that provides one-click diagnostic imaging. It brought in machine learning to make the scanning process faster, easier, and more consistent. Its platform leverages existing scanners and contains all of the mri tools needed for a comprehensive cardiac examination, with just one click.
PsiQuantum
Series C in 2020
PsiQuantum is focused on developing the first utility-scale quantum computer to address significant global challenges. The company utilizes photonic qubits, which offer substantial advantages for creating a fault-tolerant, general-purpose quantum computer. By leveraging advanced semiconductor manufacturing capabilities, PsiQuantum aims to deliver quantum technology that can foster advancements across various sectors, including climate, healthcare, finance, energy, agriculture, transportation, and communications. This innovative approach positions PsiQuantum to contribute meaningfully to solving real-world problems through enhanced computational capabilities.
Mojo Vision
Series A in 2018
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
DataRobot
Venture Round in 2018
DataRobot, Inc. is a Boston-based company that specializes in developing an automated machine learning platform aimed at empowering enterprises to construct predictive models efficiently. Its offerings include DataRobot Cloud, a cloud-based platform for predictive analytics, and DataRobot MLOps, which facilitates the deployment, monitoring, and management of machine learning models across organizations. Additionally, DataRobot Enterprise provides features tailored for large organizations, such as flexible deployment options, governance, and comprehensive support. The company's solutions cater to a diverse clientele, including business analysts, data scientists, executives, and IT professionals across various sectors such as banking, healthcare, and manufacturing. Founded in 2012, DataRobot has expanded its operations internationally, with locations in London, Paris, Kyiv, Tokyo, and Singapore, and maintains a strategic partnership with Snowflake to enhance its offerings.
Formulus Black
Venture Round in 2017
Formulus Black Corporation is a technology company specializing in in-memory computing software designed to enhance the performance of applications. Founded in 2012 and based in Jersey City, New Jersey, the company has developed a platform that enables any KVM-compatible application to operate entirely in memory. Their flagship product, ForsaOS, pools physical server memory, transforming it into a high-performance storage solution for applications that require low latency and intensive input/output operations. By reorganizing I/O data structures for efficiency, Formulus Black allows enterprises and cloud providers to maintain all data in ultrafast server memory, thereby improving application performance without necessitating code rewrites. The company is backed by venture funding and is driven by a vision to revolutionize computing.
Fathom Radiant
Venture Round in 2017
Fathom Radiant specializes in developing advanced computer hardware technology tailored for artificial intelligence applications. By integrating the strengths of optics and electronics, the company has created an innovative interconnect fabric that facilitates a flexible machine architecture with supercomputer-level network capacity and remarkable scalability. This technology enables businesses to enhance their deep learning capabilities by delivering high-performance machine learning computers, which are capable of training neural networks at scales comparable to or exceeding that of the human brain.
Cerebras Systems
Series C in 2017
Cerebras Systems Inc. is a company based in Los Altos, California, that specializes in manufacturing artificial intelligence chips tailored for deep learning applications. Founded in 2016, Cerebras Systems is dedicated to developing advanced computing systems designed to accelerate deep learning tasks. The company integrates its expertise in computer architecture and machine learning to create a new class of computer systems that significantly enhance AI performance. By employing innovative design principles, Cerebras Systems aims to transform the landscape of artificial intelligence through its pioneering technology.
Synthego
Venture Round in 2016
Synthego Corporation is a genome engineering company focused on advancing life science research and therapeutic development to improve human health. Founded in 2012 and headquartered in Redwood City, California, Synthego offers a comprehensive platform that integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology. The company's product portfolio includes engineered cells, CRISPR kits, and bioinformatics tools designed for various applications such as pathway analysis, target validation, disease modeling, and diagnostics. By leveraging machine learning and automation, Synthego enables researchers in biotechnology and academia to conduct efficient and precise gene editing, facilitating rapid advancements in drug discovery and development. The company serves a global customer base, distributing its products through various channels, including online sales and partnerships in multiple countries.
Hospital IQ
Venture Round in 2016
Hospital IQ LLC specializes in developing cloud-based software aimed at enhancing operational efficiency in hospitals. The company offers a predictive analytics platform that optimizes surgical scheduling, inpatient capacity, and discharge processes while reducing wait times and length of stay. By combining artificial intelligence, machine learning, and advanced data analytics, the platform provides hospital administrators and clinical department heads with actionable insights to improve decision-making and resource allocation. Hospital IQ's solutions are designed to streamline operations, improve patient flow, and ultimately enhance clinical outcomes and financial performance. Founded in 2013 and based in Newton, Massachusetts, Hospital IQ collaborates with leading healthcare institutions to address operational challenges and support quality improvement initiatives.
Cortical.io
Venture Round in 2016
Cortical.io specializes in artificial intelligence-based solutions for natural language understanding, focusing on the extraction, classification, review, and analysis of unstructured text. The company employs a unique, meaning-based approach known as Semantic Folding, which addresses critical challenges in text processing within business contexts. Its platform is designed to operate without supervision, providing capabilities for meaning-based filtering of unstructured data and real-time topic detection across various languages and specialized vocabularies. Cortical.io prioritizes flexibility in its business philosophy, allowing for the development of custom solutions tailored to meet the specific needs of its clients. The company has offices in New York and San Francisco in the U.S., as well as in Vienna, Europe.
Mellitus Health
Venture Round in 2016
Mellitus Health, Inc. is a healthcare technology company based in Los Angeles, California, that specializes in cloud-based insulin titration software. The company has developed Insulin Insights, an application designed to provide clinicians with precision insulin dosage recommendations. This tool allows for patient-specific dosage adjustments, enabling healthcare providers to optimize insulin regimens effectively. By facilitating more accurate insulin management, Mellitus Health aims to reduce blood glucose levels, minimize complications, and ultimately lower healthcare costs associated with diabetes treatment. Founded in 2013, the company focuses on improving the quality of care for patients requiring insulin therapy.
Cortical.io
Series A in 2015
Cortical.io specializes in artificial intelligence-based solutions for natural language understanding, focusing on the extraction, classification, review, and analysis of unstructured text. The company employs a unique, meaning-based approach known as Semantic Folding, which addresses critical challenges in text processing within business contexts. Its platform is designed to operate without supervision, providing capabilities for meaning-based filtering of unstructured data and real-time topic detection across various languages and specialized vocabularies. Cortical.io prioritizes flexibility in its business philosophy, allowing for the development of custom solutions tailored to meet the specific needs of its clients. The company has offices in New York and San Francisco in the U.S., as well as in Vienna, Europe.
Gainspeed
Series C in 2015
Gainspeed, Inc. is a technology company that specializes in a virtual Converged Cable Access Platform (CCAP), which allows cable operators to enhance network capacity and adapt to evolving market demands. Founded in 2012 and based in Sunnyvale, California, Gainspeed's solution facilitates the transition to a software-driven, all-IP architecture, accommodating the shift from traditional QAM video to IP video. This platform supports various services, including broadcast analog video, IP video, teleconferencing, and cloud computing, enabling operators to deploy new services efficiently and cost-effectively. Gainspeed operates as a subsidiary of Nokia Corporation, reflecting its integration into a larger technological ecosystem.
Smaarts
Venture Round in 2015
Smaarts, Inc., founded in 2012 and headquartered in San Mateo, California, specializes in developing software solutions for real-time detection of enterprise security infections. The company focuses on creating technology that analyzes and identifies relationships within data gathered from various security devices and other sources. By offering real-time malware and incident analysis solutions, Smaarts aims to help businesses prevent security breaches and enhance their overall cybersecurity posture.
Histide
Series A in 2014
Histide is a biotech intellectual property platform company focused on developing a new class of non-mutagenic extracellular therapeutic agents known as Cell Recoding Molecules (CRMs). This innovative approach leverages Histide's understanding of cellular microenvironmental sensing and signal transduction to enhance the cell's natural abilities to redirect its fate through accurate integration of extracellular signals. Histide's Recoding Therapeutics aim to address a wide range of diseases that are currently untreatable or undruggable, going beyond traditional therapies like cell, gene, or RNA-based treatments. The company's platform facilitates the creation of complex microenvironments that can influence the commitment of various cell types, enabling enhanced therapeutic solutions across multiple areas and routes of administration. Histide envisions establishing CRMs as a new class of therapeutic solutions, fostering collaboration among diverse teams and partners to unlock the potential of Recoding Therapeutics.
Barefoot Networks
Series A in 2014
Barefoot Networks, Inc., founded in 2013 and based in Palo Alto, California, specializes in designing and developing programmable Ethernet switch chips. The company focuses on simplifying network programming, making it as straightforward as programming a CPU. Its product offerings include advanced features for network management operations, such as scalable load balancing and enhanced telemetry, which enable enterprises, data centers, and telecom providers to implement new functionalities in their network products without sacrificing performance. As of December 31, 2019, Barefoot Networks operates as a subsidiary of Intel Corporation.
Nova
Funding Round in 2014
Nova is a technology company that aids premium publishers in enhancing revenue growth through branded content initiatives. It partners with notable organizations such as AOL, Conde Nast, News Corp, and The Telegraph to support their direct-sold branded content operations. The platform is tailored specifically for premium publishers and features tools for content distribution, campaign management, and insightful reporting. Nova's solutions are designed to increase content visibility, optimize operational efficiency, and provide measurable results to demonstrate the effectiveness of branded content. Founded in 2007 and headquartered in Toronto, Canada, Nova also maintains offices in New York City, London, and Sydney, allowing it to serve a global clientele.
Vicarious
Series B in 2014
Vicarious is an artificial intelligence company founded in 2010 by Dr. Dileep George and D. Scott Phoenix. The company develops neuro and cognitive science-based technologies aimed at creating general intelligence for robots by mimicking the functions of the human brain. Its innovative algorithmic architecture seeks to achieve human-level intelligence in areas such as vision, language, and motor control. Vicarious focuses on visual perception challenges, including recognition, segmentation, and scene parsing. This technology enables robot manufacturers to produce robots with enhanced intelligence and improved task efficiency.
SeaMicro
Venture Round in 2009
SeaMicro is a company focused on developing low power data centers through innovative server architecture. By leveraging advancements in CPU design, virtualization, supercomputing, and networking, SeaMicro has created servers that consume significantly less power—approximately one-quarter of that used by traditional servers—while occupying only one-sixth of the physical space. This efficient design addresses the growing power inefficiencies in the server market, which has seen a dramatic increase in electricity consumption over recent years. SeaMicro's servers are designed to be plug-and-play, requiring no modifications to existing software operating systems, applications, or management infrastructures, making them an attractive solution for modern data centers.
3Par
Series D in 2004
3PAR Inc. is a global provider of utility storage systems designed for mid-sized to large enterprises, financial services firms, cloud computing service providers, consumer-oriented Internet/Web 2.0 companies, and government entities. The company specializes in helping organizations create infrastructures that enable the delivery of cloud-based services, both internally and at the scale needed by service providers. 3PAR's enterprise-class storage systems are characterized by a clustered design that supports comprehensive multi-tenancy and are engineered to be self-configuring, self-optimizing, self-monitoring, self-healing, and scalable. Their products feature an integrated hardware platform, which includes an operating system and a suite of software applications for efficient data storage and information management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.